Asston Pharmaceuticals Ltd. IPO

Min Investment
₹ 1,23,000 / 1000 shares
Price Range
₹115 - ₹ 123
Bidding Dates
9 Jul '25 - 11 Jul '25
Total Issue Value
27.56 Cr
Lot Size
1,000
Total Issue Size
27.56 Cr
Listing At
BSE SME
Subscription
172.30 times
BSE Price
82.53 (-32.9%)

IPO Timeline

  • 9 Jul 2025
    Bidding Starts
  • 11 Jul 2025
    Bidding Ends
  • 14 Jul 2025
    Allotment Finalization
  • 16 Jul 2025
    Listing

About Asston Pharmaceuticals Ltd.

Our Company is engaged in the manufacturing and export of both pharmaceutical formulations and nutraceutical products in domestic and various African and Asian markets. Presently our Company is involved in the business of manufacturing and marketing of Tablets, Capsules, Oral Liquid, External ... Read more

Parent organisation
Founded
Asston Pharmaceuticals Ltd.
2019

Asston Pharmaceuticals Ltd. IPO Reservation

Investors Category Shares Offered
Anchor Investors 6,35,000 (28.34%)
Market Makers 1,13,000 (5.04%)
Non Institutional Investors 3,22,000 (14.37%)
Qualified Institutional Buyers (QIBs) 4,25,000 (18.96%)
Retail Individual Investors (RIIs) 7,46,000 (33.29%)

Asston Pharmaceuticals Ltd. Financial Information

Year End Revenue PAT Reserves & Surplus
31 Mar 2025 25.61 Cr 4.33 Cr 4.45 Cr
31 Mar 2024 15.84 Cr 1.36 Cr 5.61 Cr
31 Mar 2023 7.19 Cr 1.06 Cr 1.29 Cr

Asston Pharmaceuticals Ltd. Background

Our Company was originally incorporated as “Asston Pharmaceuticals Private Limited”, a private limited company under Companies Act, 2013, pursuant to a certificate of incorporation dated April 16, 2019 issued by Registrar of Companies, Mumbai, Maharashtra. Thereafter, our Company was ...

Read more

Major Events And Milestones
  • 2019
    Incorporation of our Company viz. “Asston Pharmaceuticals Private Limited” under the guidance and leadership of Dr. Ashish Narayan Sakalkar and Mrs. Saili Jayaram More.
    Our Company obtained Trade and Export Licenses for 3 major west African Countries namely Sierra Leone, Ghana and Liberia.
  • 2020
    Our Company obtained registered trademarks in both India and abroad for multiple products,enhancing its images as a pharmaceutical brand in late 2020.
  • 2021
    Our Company crossed the turnover of 10 cr turnover mark in 2021, less than two years since inception.
  • 2022
    Established our Manufacturing unit in Mumbai which is one of our Company’s achievement making us an independent and reliable supplier.
  • 2023
    Our Company has successfully ventured into other African countries and is expected to receive registration from Asian markets like Cambodia and Vietnam.
  • 2024
    Conversion of our Company from Private Limited to Public Limited Company.
Asston Pharmaceuticals Ltd. Object of Issues

1. Funding capital expenditure requirements towards acquiring machinery in the manufacturing unit
2. Funding the incremental working capital requirements of our Company
3. Repayment and/or prepayment, in part or full, of certain of our outstanding borrowings availed by our Company
4. General Corporate Purposes

Asston Pharmaceuticals Ltd. IPO Listing Details
Listing Date
16 Jul 2025
BSE Script Code
ASSTON
ISIN
INE0SJX01015
Final Issue Price
₹ 123
Asston Pharmaceuticals Ltd. Listing Day Trading Information
Pricing Details BSE NSE
Issue Price ₹ 123.00 -
Open ₹ 119.00 -
Low ₹ 113.05 -
High ₹ 124.95 -
Last Trade ₹ 124.95 -
Asston Pharmaceuticals Ltd. Company Promoters

1. Dr. Ashish Narayan Sakalkar
2. Saili Jayaram More
3. Sachin Chandrakant Badakh

Industry Overview

Indian pharmaceutical industry has a strong presence at the global level. “Pharmacy of the world” as it is often called offers around 60,000 generic brands across 60 therapeutic categories, accounting for 20 per cent of global generic drug exports by volume. Not surprisingly, eight of ... Read more

Asston Pharmaceuticals Ltd. Contact Details
Address: 4th Floor, Office No A-431, Balaji Bhavan, Plot No 42A Sector-11, CBD Belapur, Navi Mumbai, Thane Maharashtra - 400614
Phone no:49731411, 49731419, 9819910230
49731411, 49731419, 9819910230
|
Asston Pharmaceuticals Ltd. IPO Registrar
Maashitla Securities Pvt. Ltd.
451, Krishna Apra Business Square, Netaji Subhash Place, Pitampura Delhi - 110034
45121795, 45121796
Asston Pharmaceuticals Ltd. IPO Lead Manager(s)
Sobhagya Capital Options Pvt. Ltd.
C-7 to C-7A, Gate No-01, Hosiery Complex, Phase-II Extension, Noida Uttar Pradesh - 201305
7836066001

FAQs

When does Asston Pharmaceuticals Ltd. IPO opens and closes?

Asston Pharmaceuticals Ltd. IPO opens from 9th July to 11th July 2025.

What is the size of Asston Pharmaceuticals Ltd. IPO?

The size of the Asston Pharmaceuticals Ltd. IPO is ₹27.56 Cr.

What is the price range of Asston Pharmaceuticals Ltd. IPO?

The price range of Asston Pharmaceuticals Ltd. IPO is at ₹115 to ₹123 per share.

What is the minimum investment and lot size required for the Asston Pharmaceuticals Ltd. IPO?

The minimum investment required is ₹1,23,000 and minimum lot size is 1000 shares.

When is Asston Pharmaceuticals Ltd. IPO listing date?

The Asston Pharmaceuticals Ltd. IPO will be listed on 16th July 2025.

What is the objective of Asston Pharmaceuticals Ltd. IPO?

1. Funding capital expenditure requirements towards acquiring machinery in the manufacturing unit
2. Funding the incremental working capital requirements of our Company
3. Repayment and/or prepayment, in part or full, of certain of our outstanding borrowings availed by our Company
4. General Corporate Purposes

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article

Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
  • Block for 8 hours
  • Block for 12 hours
  • Block for 24 hours
  • Don't block
Gender
Select your Gender
  • Male
  • Female
  • Others
Age
Select your Age Range
  • Under 18
  • 18 to 25
  • 26 to 35
  • 36 to 45
  • 45 to 55
  • 55+